A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors
Author:
Funder
National Natural Science Foundation of China
Zhengzhou University
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference149 articles.
1. Global Diffusion of eHealth: Making Universal Health Coverage Achievable: Report of the Third Global Survey on eHealth;Organization,2017
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018
3. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression;Feinberg;Nat. Rev. Genet.,2016
4. An epigenetic view of developmental diseases: new targets, new therapies;Xie;World J. Pediatrics : WJP,2016
5. Epigenetics and health disparities;Vick;Current Epidemiol. Rep.,2017
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epigenetic Inhibitors as Alzheimer’s Disease Therapeutic Agents;Chemical and Pharmaceutical Bulletin;2024-07-01
2. Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors;Journal of Cancer Research and Clinical Oncology;2024-05-15
3. Anticancer Drugs of Lysine Specific Histone Demethylase-1 (LSD1) Display Variable Inhibition on Nucleosome Substrates;Biochemistry;2024-05-14
4. Inhibition of LSD1 via SP2509 attenuated the progression of rheumatoid arthritis;Immunologic Research;2024-05-09
5. Research progress of LSD1-based dual-target agents for cancer therapy;Bioorganic & Medicinal Chemistry;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3